Clinical Trials Browser

Carcinoma, Hepatocellular × pasireotide × Clear all

NCT01639352 2017-07-12

Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular Carcinoma

Phase 2 Completed

20 enrolled 12 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT01488487 2016-04-07

Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma

Phase 2 Completed

24 enrolled 17 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms